← ANALYSTS · TIPRANKS
Jonathan Miller · Evercore ISI
Hits
41%
20 of 49 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−3.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
15
Buy / hold / sell: 15 / 0 / 0
Upside of the analyst’s targets
+367.6%
Average over 13 current targets, to the last price
The market’s answer to the ratings
−2.3%
Day-0 move against SPY in the rating’s direction, average over 7 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 15on TipRanks Oct 16 03:25 | TRDAIWMEntrada Therapeutics Inc · $177M | Reiterated | Buy | $25.00 | +472.1% | +4.8%next day −7.5% | ↗ |
| Sep 29on TipRanks 09:11 | ZYMEIWMZymeworks · $1.8B | Reiterated | Buy | $44.00 | +75.8% | +0.5%next day −2.4% · 5 days −7.6% | ↗ |
| Aug 31on TipRanks 09:15 | CRSPIWMCrispr Therapeutics AG · $5.0B | Reiterated | Buy | $76.00 | +54.3% | −1.0%next day +0.4% · 5 days −3.7% | ↗ |
| Aug 10on TipRanks 08:20 | ARVNIWMArvinas Holding Company · $468M | Assigned | Buy | $19.00 → $14.00−26.3% | +100.9% | +2.8%next day +0.3% · 5 days +2.4% | ↗ |
| Aug 7on TipRanks 07:55 | NTLAIWMIntellia Therapeutics · $1.6B | Upgrade | Buy | $16.00 → $24.00+50.0% | +110.2% | +5.6%next day +0.7% · 5 days −0.7% | ↗ |
| Jul 20on TipRanks Jul 24 05:14 | FDMTIWM4D Molecular Therapeutics · $711M | Reiterated | Buy | $23.00 | +89.5% | +1.1%next day +1.7% · 5 days −6.0% | ↗ |
| May 27on TipRanks 11:05 | EDITIWMEditas Medicine · $375M | Reiterated | Buy | $15.00 | +538.3% | +15.9%next day −4.5% · 5 days −22.6% | ↗ |
| May 18on TipRanks 08:45 | NKTXIWMNkarta · $138M | Reiterated | Buy | $25.00 → $9.00−64.0% | +400.0% | +1.6%next day +0.7% · 5 days +12.6% | ↗ |
| May 11on TipRanks 08:15 | JANXIWMJanux Therapeutics Inc · $1.1B | Reiterated | Buy | $23.00 → $22.00−4.3% | +33.3% | +0.2%next day +1.4% · 5 days −1.3% | ↗ |
| May 5on TipRanks 10:05 | TRDAIWMEntrada Therapeutics Inc · $177M | Reiterated | Buy | $25.00 | +472.1% | −1.1%next day +0.4% · 5 days −56.8% | ↗ |
| Apr 28on TipRanks 09:25 | ERASIWMErasca · $5.2B | Reiterated | Buy | $11.00 → $24.00+118.2% | +79.2% | −47.8%next day −8.0% · 5 days −0.8% | ↗ |
| Apr 13on TipRanks 09:50 | AURAIWMAura Biosciences Inc · $657M | Reiterated | Buy | $13.00 → $15.00+15.4% | +145.9% | +0.6%next day +1.4% · 5 days −1.3% | ↗ |
| Mar 9on TipRanks Mar 10 01:10 | CRBUIWMCaribou Biosciences · $50M | Reiterated | Buy | $11.00 → $13.00+18.2% | +2,671.9% | +7.4%next day +3.2% · 5 days −3.7% | ↗ |
| Mar 2on TipRanks Mar 3 04:15 | RCUSIWMArcus Biosciences · $2.9B | Reiterated | Buy | — | — | +17.5%next day −5.4% · 5 days −0.9% | ↗ |
| Jan 26on TipRanks Jan 27 05:21 | OKURIWMOnKure Therapeutics · $91M | Reiterated | Buy | — | — | −6.3%next day +2.9% · 5 days −4.7% | ↗ |
| Sep 30on TipRanks Oct 1 06:15 | ENTAIWMEnanta Pharmaceuticals · $334M | Reiterated | Buy | $12.00 | +8.1% | −21.4%next day −11.7% · 5 days −7.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗